CPC
RPRX icon

Cookson Peirce & Co’s Royalty Pharma RPRX Stock Holding History

Cookson Peirce & Co’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.4M Buy
398,854
+10,370
+3% +$540K 0.74% 38
2026
Q1 		$18.6M Buy
388,484
+11,869
+3% +$520K 0.79% 42
2025
Q4 		$14.6M Buy
376,615
+3,729
+1% +$142K 0.6% 48
2025
Q3 		$13.2M Buy
372,886
+338,623
+988% +$12.3M 0.54% 53
2025
Q2 		$1.23M Buy
34,263
+12,171
+55% +$403K 0.05% 137
2025
Q1 		$688K Buy
+22,092
New +$700K 0.03% 189

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cookson Peirce & Co's RPRX Position: Q2 2026 in Review

Cookson Peirce & Co increased its Royalty Pharma (RPRX) stake by 2.7% in Q2 2026, buying an estimated $540K and bringing the position to 398,854 shares worth $22.4M. The position accounts for 0.74% of the portfolio, ranked #38.

Cookson Peirce & Co first reported a position in RPRX in Q1 2025 and has held it in 6 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Cookson Peirce & Co held 398,854 shares of Royalty Pharma worth $22.4M as of Q2 2026.
  • Cookson Peirce & Co bought 10,370 Royalty Pharma shares in Q2 2026, an estimated $540K.
  • Royalty Pharma made up 0.74% of Cookson Peirce & Co's portfolio in Q2 2026, its #38 holding.
  • Cookson Peirce & Co first reported a position in Royalty Pharma in Q1 2025 and has held it in 6 quarters since.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.